![Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0048969712013927-fx1.jpg)
Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect
Periprocedural Guidelines for the Management of Patients on long-term Anticoagulant and Antiplatelet Agents
![Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0048969712013927-gr1.jpg)
Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect
![Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7013e3_COVIDVaccineFieldEffectiveness_IMAGE_29Mar21_v2_1200x627.jpg?_=23735)
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
![Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial - The Lancet Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/asset/4caea958-3c14-4b01-a0b6-7124b02db1e2/gr1.jpg)
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial - The Lancet
![Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35653-z/MediaObjects/41467_2022_35653_Fig1_HTML.png)
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications
![Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA](https://www.fda.gov/files/Booster%20Infographic_D_Rev_010622_0.png)
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
Real-World Midazolam Use and Outcomes With Out-of-Hospital Treatment of Status Epilepticus in the United States
![DepoDur™: A New Drug Formulation With Unique Safety Considerations - Anesthesia Patient Safety Foundation DepoDur™: A New Drug Formulation With Unique Safety Considerations - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/newsletters/2005/fall/fig2-3.jpg)
DepoDur™: A New Drug Formulation With Unique Safety Considerations - Anesthesia Patient Safety Foundation
![Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice | Nature Communications Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26714-w/MediaObjects/41467_2021_26714_Fig1_HTML.png)
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice | Nature Communications
![emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education](http://www.emdocs.net/wp-content/uploads/2019/04/Screen-Shot-2019-04-21-at-5.23.21-PM.png)
emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education
![Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet](https://www.thelancet.com/cms/asset/04f3d1bc-8493-4bfa-9572-fc2f5606352f/gr1.jpg)
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial - The Lancet
![Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/db5c63dc-ee49-4b78-b05c-e93ffa8229af/gr1_lrg.jpg)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
![Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments | Journal of Clinical Oncology Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2021/jco.2021.39.issue-9/jco.20.02768/20210308/images/large/jco.20.02768t1.jpeg)